Navigation Links
DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments
Date:8/29/2014

previous glioblastoma clinical trials conducted by the National Cancer Institutes in the United States. The Company believes that such higher doses may enhance the potential of VAL-083 to impact a patent's tumor and improve patient outcomes. Ultimately, DelMar believes advancing to higher doses will increase the chance of success in achieving the longer-term goal to commercialize VAL-083 as a new chemotherapy for glioblastoma patients who have failed, or are unlikely to respond, to currently available treatments.
  • DelMar presented new non-clinical research supporting the potential utility of VAL-083 in the treatment of non-small cell lung cancer at AACR in April.
  • DelMar received an additional CDN $194,000 nonrefundable funding contribution from that National Research Council of Canada (NRC). Four non-dilutive funding contributions to date from NRC total CDN $327,000 and will be used to support continued non-clinical research aimed at providing competitive differentiation for VAL-083 as a new medicine in the treatment of glioblastoma and other cancers, including non-small cell lung cancer.
  • DelMar received gross proceeds of $2,373,937 from the exercise of warrants at $0.65 per warrant that closed on June 6 and an additional $495,448 in gross proceeds from exercise of these warrants under the tender offer which closed on August 8. The exercise of warrants through a private transaction with certain warrant holders and subsequent tender offer has provided the Company with additional non-dilutive capital, which the Company believes will be sufficient to fund current operations through at least the end of December 2015. 
  • Jeffrey Bacha, president & CEO of DelMar Pharmaceuticals stated, "We are pleased with the overall progress made during the past year in research and development activities. The warrant tender offer and change in our fiscal year end are part of our ove
    '/>"/>

    SOURCE DelMar Pharmaceuticals, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
    2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
    3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
    4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
    5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
    6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
    7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
    8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
    9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
    10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
    11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/27/2014)... , Nov. 27, 2014 ... to Academic Research - JIN Co., Ltd. will ... a market price of 500,000 yen or $5,000 (without tax ... software). The "ACADEMIC PACK" is a dedicated solution of "JINS ... capture and analyze deep data* generated by electrooculography and six-axis ...
    (Date:11/26/2014)... -- Cohen, Placitella & Roth, PC is investigating potential ... Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 2011 through November 2, 2014 ("Class Period").  The ... officers and directors publically disseminated materially false and/or ... 20(a) of the Securities Exchange Act of 1934 ...
    (Date:11/26/2014)... Md. , Nov. 26, 2014  Over 100 ... of those suffer from this pain daily. Chronic and ... of pain management is born to fulfill the need ... all types of pain. On October 28th, ... the Cumberland, Maryland community.  This ...
    Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3New Pain Management Center Opens in Cumberland, Md. 2
    ... Inc. (NYSE: MTD ) today announced the webcast ... in New York on Wednesday, September 21, 2011, at 9:00 ... presentation, visit the investor relations page on the Company,s Web ... will be available for seven days. METTLER TOLEDO ...
    ... Micross Components, a leading global provider of ... Manager of its US Products & Services Division. ... business development, will play a leading role in ... to increase market share across several key business ...
    Cached Medicine Technology:Micross Components Names Mike Deley as General Manager of US Products & Services Division 2
    (Date:11/27/2014)... The American Society for Clinical Pathology (ASCP) ... in honor of World AIDS Day 2014. On Nov. 25, ... cure.” icon and infographic designed to generate public awareness about ... HIV. , ASCP has asked members to replace their Facebook, ... Get Tested. Find a cure.” icon and share the accompanying ...
    (Date:11/27/2014)... Luciana Lagana and her husband ... a feature film that received 9 awards at the 2014 ... cast. It is also an official selection of the 2014 ... successful cinematic career for James Noel, a young filmmaker who ... experimental mystery, filmed in glorious black and white, watching Omadox ...
    (Date:11/27/2014)... An inventor from Buffalo, N.Y., knows that many ... she wants to lessen its impact. "After showering and ... there needed to be a way to maintain freshness ... and producible in design variations, the End Scentuous Body ... the day. It avoids bad odors, as well as ...
    (Date:11/27/2014)... WEDNESDAY, Nov. 26, 2014 (HealthDay News) -- Most babies ... a cold, the U.S. Food and Drug Administration says. ... be given to children younger than 2 because they ... agency warned. American adults average about three colds ... children get a cold, parents might want to give ...
    (Date:11/27/2014)... (PRWEB) November 27, 2014 The founders of ... stylish, comfortable and high functioning compression socks, are proud to ... socks use an innovative Gradient Pressure (TM) knitting technology that ... , VIM & VIGR’s commitment to adding flair and style ... just functional recently caught the eye of a writer at ...
    Breaking Medicine News(10 mins):Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 3Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2
    ... to manage the ever-increasing health care cost and increase the ... has urged the citizens to invest // in health saving ... time of need, the funds can be mobilized to pay ... policies and lowest annual premium rates are coupled with the ...
    ... by Margaret Marshall of Seattle Pacific University and Jonathon Brown ... of expecting the worst results after an examination does not ... such defensive pessimism are not better off than their normal ... journal Cognition and Emotion, the excretes of which appear in ...
    ... two-year-old daughter were drowned in the River Ganga after a ... two were witches//. Police were able to recover their bodies ... of the state. ,They had initially suspected suicide. ... wage laborer, was very obsessed with her daughter and kept ...
    ... last two decades in chains in a small village called ... said that Mansharam did not move at all and spent ... says that Mansharam was chained to a post after he ... lot of money to get him treated but nothing helped. ...
    ... market is on the rise and is also being ... given to patients// under 18 because of serious safety ... is the long waiting periods for suitable therapies like ... Prozac which is recommended for under-18s still lots of ...
    ... Mason resulted in the death of A&M University ... County traffic investigators have indicated that it was ... damage to the cars indicates that the cars ... Toxicity reports are being awaited by the ...
    Cached Medicine News:Health News:President Bush Urges Citizens to Invest In Health Savings Account (HSAs) 2Health News:Antidepressants still being prescribed to Teenagers despite being banned! 2
    For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
    For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
    For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
    For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
    Medicine Products: